{"id":22966,"date":"2025-12-22T11:15:26","date_gmt":"2025-12-22T09:15:26","guid":{"rendered":"https:\/\/www.invaldainvl.com\/?p=22966"},"modified":"2026-01-07T17:30:15","modified_gmt":"2026-01-07T15:30:15","slug":"invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care","status":"publish","type":"post","link":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/","title":{"rendered":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0"},"content":{"rendered":"\n
\n\t\t\t\t\t
\n\t\t\t\t\t\t

A consortium of\u00a0the\u00a0INVL Private Equity Fund II,\u00a0one of the largest private equity funds in Central and Eastern Europe,\u00a0the International Finance Corporation (IFC), and Accession Capital Partners (ACP) has completed\u00a0an\u00a0investment in\u00a0POLMED, one of Poland\u2019s largest healthcare groups. POLMED\u00a0is\u00a0using\u00a0the proceeds to\u00a0acquire\u00a0the\u00a0KN Group, an operator of oncology centers.<\/span><\/b>\u00a0<\/span><\/p>\n

\u201cAs new strategic partners of POLMED, we are embarking on an ambitious expansion\u00a0with them. The acquisition of\u00a0the\u00a0KN Group\u00a0immediately\u00a0strengthens the group\u2019s\u00a0expertise\u00a0and market position in oncology.\u00a0We\u00a0aim to create Poland\u2019s premier healthcare provider, one that is\u00a0modern and accessible\u00a0all\u00a0across\u00a0the country. For patients, this will translate into the highest quality of care and a broad spectrum of diagnostic services,\u201d says Luke\u00a0Staniczek,\u00a0the\u00a0Investments Lead in Poland at\u00a0the\u00a0INVL Private Equity Fund II.\u00a0<\/span>\u00a0<\/span><\/p>\n

\u201cWe believe that the expansion of P<\/span>OLMED<\/span>\u00a0will further strengthen its ability to provide the highest-quality services to its patients, whose health and well-being remain top priority for us,\u201d adds\u00a0Nerijus\u00a0Drobavi\u010dius,\u00a0a\u00a0Partner at\u00a0the\u00a0INVL Private Equity Fund II.<\/span>\u00a0<\/span><\/p>\n

Following the\u00a0consortium\u2019s\u00a0investment, the majority stake in POLMED continues to be held by the group\u2019s\u00a0Founder and President, Rados\u0142aw\u00a0Szubert,\u00a0together\u00a0with\u00a0Co-founder and Vice-President Romuald\u00a0Magdo\u0144, while\u00a0the\u00a0<\/span>INVL\u00a0Private\u00a0Equity\u00a0Fund\u00a0II,\u00a0the\u00a0IFC\u00a0and\u00a0ACP\u00a0each\u00a0hold\u00a0significant\u00a0minority\u00a0stakes.<\/span>\u00a0<\/span><\/p>\n

Founded in 1999, POLMED has grown into one of Poland\u2019s largest private healthcare service groups,\u00a0with revenue in 2024 exceeding EUR 100 million.\u00a0The company provides outpatient care, diagnostic imaging, and inpatient and home rehabilitation services. With 38 facilities of its own,\u00a0including 380 hospital beds and a team of\u00a0approximately\u00a02,000 employees, it also collaborates with\u00a0more than\u00a04,000 medical partners across Poland, serving more than 4 million patients annually and providing services to over 3,500 companies.<\/span>\u00a0<\/span><\/p>\n

The\u00a0KN Group\u00a0operates\u00a0three oncology centers in Radom and Warsaw:\u00a0the\u00a0Radom Oncology Center,\u00a0the\u00a0Gamma Knife Centre, and the Radom Family Center,\u00a0with\u00a0combined\u00a02024\u00a0revenues\u00a0of EUR 54.5 million.\u00a0The group employs over 700\u00a0people\u00a0and has approximately 150 beds, including 14 chemotherapy chairs. It is led by the internationally renowned neurosurgeon\u00a0Prof. Miros\u0142aw Z\u0105bek\u00a0and\u00a0Managing Director\u00a0Dorota\u00a0Z\u0105bek, both of whom will continue in their roles within the company.<\/span>\u00a0<\/span><\/p>\n

POLMED marks\u00a0the\u00a0second investment\u00a0completed\u00a0by\u00a0the\u00a0INVL Private Equity Fund II, which announced its final closing earlier this year\u00a0at\u00a0EUR 410 million,\u00a0above\u00a0the\u00a0hard\u00a0cap.\u00a0<\/span>The fund is in\u00a0its\u00a0active investment phase.\u00a0It\u00a0is targeting companies with enterprise values of EUR 30 million to EUR 200\u202fmillion\u00a0or more\u00a0across Baltics, Poland,\u00a0Romania\u00a0and\u00a0the\u00a0broader EU.<\/span>\u00a0<\/span>\u00a0<\/span><\/p>\n

About\u00a0the\u00a0INVL Private Equity Fund II\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n

With EUR 410\u00a0million\u00a0of\u00a0commitments,\u00a0this\u00a0is the largest private equity fund in the Baltics and one of the largest in\u00a0Central and Eastern Europe.\u00a0The fund is sector-agnostic and is looking to build a diversified portfolio investing in companies with the potential to become regional leaders in their respective industries.\u00a0Equity tickets\u00a0range\u00a0between EUR 10 million\u00a0and\u00a0EUR 60 million, though\u00a0larger\u00a0tickets\u00a0are possible\u00a0with co-investors.\u00a0The\u00a0fund is\u00a0seeking\u00a0majority or significant minority stakes where it could drive long-term value creation. The focus is on businesses with strong potential to grow and compete amid intensifying global competition. Geographically,\u00a0the fund is targeting opportunities in the Baltic countries, Poland, and the broader Europe Union.<\/span>\u00a0<\/span><\/p>\n

The fund is managed by INVL Asset Management, the leading Baltic alternative asset manager, which is a part of the\u00a0Invalda\u00a0INVL Group with over 30 years of experience.\u00a0The group\u2019s companies\u00a0more\u00a0than\u00a0EUR 2 billion in assets\u00a0under\u00a0management\u00a0or supervision across various investment strategies,\u00a0<\/span>including private equity, forests and agricultural land, renewable energy, real estate, and private debt. Additionally, the group provides family office services in Lithuania,\u00a0Latvia\u00a0and Estonia, manages pension funds in Latvia,\u00a0and invests in global third-party funds.<\/span>\u00a0<\/span><\/p>\n

About IFC<\/span><\/b>\u00a0<\/span><\/p>\n

IFC – a member of the World Bank Group – is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2025, IFC committed a record $71.7 billion to private companies and financial institutions in developing countries,\u00a0leveraging\u00a0private sector\u00a0solutions\u00a0and mobilizing private capital to create a world free of poverty on a livable planet.\u00a0For more information, visit\u00a0<\/span>www.ifc.org<\/span><\/a>.\u00a0<\/span>\u00a0<\/span><\/p>\n

About the\u00a0Accession Capital Partners (ACP)<\/span><\/b>\u00a0<\/span><\/p>\n

Accession Capital Partners (ACP) is investing from its fifth fund, the\u00a0AMC V SCA SICAV-RAIF,\u00a0which closed at EUR 336 million in June 2024.\u00a0ACP has been\u00a0operating\u00a0in Central Europe since\u00a0the year\u00a02000 through its offices in Vienna, Warsaw, Bucharest,\u00a0Budapest\u00a0and Prague. To date, the group has raised commitments of more than EUR 1.2 billion in five dedicated growth capital funds. The funds are backed by reputable institutional investors, including the European Investment Fund, the International Finance Corporation, the European Bank for Reconstruction and Development and\u00a0a number of\u00a0banks, family offices, funds of funds, pension funds and insurance companies from Europe, the US and Asia.<\/span>\u00a0<\/span><\/p>\n

Important information<\/span><\/b>\u00a0<\/span><\/p>\n

This is a marketing communication of an information nature, which is not and shall not be construed as an offer to purchase investment units of a collective investment undertaking, an investment recommendation, or investment research, as it is not designed to\u00a0take into account\u00a0the investment objectives, financial situation, or needs\u00a0of any individual investor.\u00a0<\/span>\u00a0<\/span><\/p>\n

When investing,\u00a0the investors\u00a0assume the risk associated with the investment. The value of investments can both rise and fall, and investors may recover less than they\u00a0invested. Past investment results do not guarantee the same results or profitability in the future. Past performance is not a reliable indicator of future performance. Before making a decision to invest, potential investors should, on their own or with the help of investment advisers, assess the suitability of the investment for them along with the taxes and fees related to the investment, consider all the risks related to the investment, and carefully read the rules, prospectus and other documents of the respective collective investment undertaking.\u00a0<\/span>\u00a0<\/span><\/p>\n

Units of the collective investment undertaking mentioned in this press release may only be distributed to informed investors as defined in the Law on Collective Investment Undertakings for Informed Investors of the Republic of\u00a0Lithuania, as amended and supplemented from time to time, and may not be distributed or transferred to any other clients.<\/span>\u00a0<\/span><\/p>\n\t\t<\/div>\n\t<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":19,"featured_media":22722,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-22966","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-group-company-press-releases"],"acf":[],"yoast_head":"\nINVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL<\/title>\n<meta name=\"description\" content=\"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL\" \/>\n<meta property=\"og:description\" content=\"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Invalda INVL\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-22T09:15:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-07T15:30:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ramun\u0117 Vilkoityt\u0117\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ramun\u0117 Vilkoityt\u0117\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\"},\"author\":{\"name\":\"Ramun\u0117 Vilkoityt\u0117\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512\"},\"headline\":\"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0\",\"datePublished\":\"2025-12-22T09:15:26+00:00\",\"dateModified\":\"2026-01-07T15:30:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\"},\"wordCount\":14,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg\",\"articleSection\":[\"Group company press releases\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\",\"url\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\",\"name\":\"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg\",\"datePublished\":\"2025-12-22T09:15:26+00:00\",\"dateModified\":\"2026-01-07T15:30:15+00:00\",\"author\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512\"},\"description\":\"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage\",\"url\":\"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg\",\"contentUrl\":\"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.invaldainvl.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.invaldainvl.com\/#website\",\"url\":\"https:\/\/www.invaldainvl.com\/\",\"name\":\"Invalda INVL\",\"description\":\"Invalda INVL\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.invaldainvl.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512\",\"name\":\"Ramun\u0117 Vilkoityt\u0117\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/efadbce19d73b392fdc1703cc523f4cf44388cfa6e3c483b96db0bac3874a492?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/efadbce19d73b392fdc1703cc523f4cf44388cfa6e3c483b96db0bac3874a492?s=96&d=mm&r=g\",\"caption\":\"Ramun\u0117 Vilkoityt\u0117\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL","description":"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL","og_description":"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.","og_url":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/","og_site_name":"Invalda INVL","article_published_time":"2025-12-22T09:15:26+00:00","article_modified_time":"2026-01-07T15:30:15+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg","type":"image\/jpeg"}],"author":"Ramun\u0117 Vilkoityt\u0117","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ramun\u0117 Vilkoityt\u0117","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#article","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/"},"author":{"name":"Ramun\u0117 Vilkoityt\u0117","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512"},"headline":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0","datePublished":"2025-12-22T09:15:26+00:00","dateModified":"2026-01-07T15:30:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/"},"wordCount":14,"commentCount":0,"image":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg","articleSection":["Group company press releases"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/","url":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/","name":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0 - Invalda INVL","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg","datePublished":"2025-12-22T09:15:26+00:00","dateModified":"2026-01-07T15:30:15+00:00","author":{"@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512"},"description":"The Vilnius Book Fair is turning a new page in its history. For the first time, the organisers of the event taking place in February 2026 are introducing an official corporate patron \u2013 Invalda INVL, an asset management group \u2013 and a cultural programme partner, Lithuania\u2019s largest bookstore chain, Pegasas.","breadcrumb":{"@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#primaryimage","url":"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg","contentUrl":"https:\/\/www.invaldainvl.com\/wp-content\/uploads\/2025\/10\/POLMED-photo.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.invaldainvl.com\/en\/group-company-press-releases\/invl-private-equity-fund-ii-ifc-acp-back-polmeds-expansion-in-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.invaldainvl.com\/en\/"},{"@type":"ListItem","position":2,"name":"INVL Private Equity Fund II, IFC, ACP back POLMED\u2019s expansion in cancer care\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.invaldainvl.com\/#website","url":"https:\/\/www.invaldainvl.com\/","name":"Invalda INVL","description":"Invalda INVL","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.invaldainvl.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/f3b4c5df6df46108bba9e6318f257512","name":"Ramun\u0117 Vilkoityt\u0117","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/efadbce19d73b392fdc1703cc523f4cf44388cfa6e3c483b96db0bac3874a492?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/efadbce19d73b392fdc1703cc523f4cf44388cfa6e3c483b96db0bac3874a492?s=96&d=mm&r=g","caption":"Ramun\u0117 Vilkoityt\u0117"}}]}},"_links":{"self":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/22966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/comments?post=22966"}],"version-history":[{"count":1,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/22966\/revisions"}],"predecessor-version":[{"id":22967,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/22966\/revisions\/22967"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/media\/22722"}],"wp:attachment":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/media?parent=22966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/categories?post=22966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/tags?post=22966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}